Dario Cattaneo

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. doi request reprint Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients
    Dario Cattaneo
    CNR Institute of Neuroscience and Unit of Clinical Pharmacology, Department of Clinical Sciences, Luigi Sacco University Hospital, Universita di Milano, Via GB Grassi 74, 20157 Milano, Italy
    Fundam Clin Pharmacol 27:216-22. 2013
  2. doi request reprint Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Via G B Grassi 74, 20157 Milan, Italy
    Int J Antimicrob Agents 41:586-9. 2013
  3. pmc Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing
    Dario Cattaneo
    Department of Infectious Diseases, L Sacco University Hospital, Milan, Italy
    Antimicrob Agents Chemother 56:6132-6. 2012
  4. doi request reprint Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Universita di Milano, Milan, Italy
    J Antimicrob Chemother 67:460-4. 2012
  5. doi request reprint Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Universita di Milano, Milan, Italy
    Fundam Clin Pharmacol 26:204-6. 2012
  6. doi request reprint Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Via GB Grassi 74, 20157 Milano, Italy
    J Clin Pharmacol 52:440-5. 2012
  7. doi request reprint Optimizing immunosuppressive drug dosing in pediatric renal transplantation. Part of a special series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, University of Milan, Via G B Grassi 74, Milan, Italy
    Pharmacol Res 65:163-7. 2012
  8. doi request reprint Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Via GB Grassi, 74, 20157 Milan, Italy
    J Clin Pharmacol 49:773-81. 2009
  9. doi request reprint Exposure-related effects of atazanavir on the pharmacokinetics of raltegravir in HIV-1-infected patients
    Dario Cattaneo
    Unit of Clinical Pharmacology, Department of Clinical Sciences, Luigi Sacco University Hospital, Universita di Milano, Milan, Italy
    Ther Drug Monit 32:782-6. 2010
  10. doi request reprint Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection
    Dario Cattaneo
    Unit of Clinical Pharmacology, Department of Preclinical Sciences, University Hospital Luigi Sacco, Universita di Milano, Milan, Italy
    Ther Drug Monit 32:520-4. 2010

Collaborators

Detail Information

Publications31

  1. doi request reprint Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients
    Dario Cattaneo
    CNR Institute of Neuroscience and Unit of Clinical Pharmacology, Department of Clinical Sciences, Luigi Sacco University Hospital, Universita di Milano, Via GB Grassi 74, 20157 Milano, Italy
    Fundam Clin Pharmacol 27:216-22. 2013
    ..These models could be used to predict atazanavir exposure for clinic or research purposes...
  2. doi request reprint Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Via G B Grassi 74, 20157 Milan, Italy
    Int J Antimicrob Agents 41:586-9. 2013
    ..Accordingly, application of therapeutic drug monitoring may improve the safety outcome of patients receiving LNZ therapy...
  3. pmc Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing
    Dario Cattaneo
    Department of Infectious Diseases, L Sacco University Hospital, Milan, Italy
    Antimicrob Agents Chemother 56:6132-6. 2012
    ..This is related to problems in tablet disintegration and to erratic drug absorption. The amelioration of the RAL pharmaceutical formulation could improve drug pharmacokinetics...
  4. doi request reprint Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Universita di Milano, Milan, Italy
    J Antimicrob Chemother 67:460-4. 2012
    ..The present study was designed to evaluate in parallel the inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected patients during routine therapeutic drug monitoring (TDM)...
  5. doi request reprint Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Universita di Milano, Milan, Italy
    Fundam Clin Pharmacol 26:204-6. 2012
    ..This case underlines the importance of traditional and pharmacogenetic-based TDM for the individualization of ATV therapy in HIV-1 patients...
  6. doi request reprint Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Via GB Grassi 74, 20157 Milano, Italy
    J Clin Pharmacol 52:440-5. 2012
    ..These models could used to predict raltegravir exposure for clinic or research purposes...
  7. doi request reprint Optimizing immunosuppressive drug dosing in pediatric renal transplantation. Part of a special series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, University of Milan, Via G B Grassi 74, Milan, Italy
    Pharmacol Res 65:163-7. 2012
    ....
  8. doi request reprint Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen
    Dario Cattaneo
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Via GB Grassi, 74, 20157 Milan, Italy
    J Clin Pharmacol 49:773-81. 2009
    ..These tools provide additional information to optimize SRL therapeutic drug monitoring in renal transplant recipients...
  9. doi request reprint Exposure-related effects of atazanavir on the pharmacokinetics of raltegravir in HIV-1-infected patients
    Dario Cattaneo
    Unit of Clinical Pharmacology, Department of Clinical Sciences, Luigi Sacco University Hospital, Universita di Milano, Milan, Italy
    Ther Drug Monit 32:782-6. 2010
    ..This pharmacokinetic drug interaction could be handled by routine measurements of ATV trough concentrations and by the assessment of plasma RAL concentrations 2 to 3 hours after the morning drug intake...
  10. doi request reprint Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection
    Dario Cattaneo
    Unit of Clinical Pharmacology, Department of Preclinical Sciences, University Hospital Luigi Sacco, Universita di Milano, Milan, Italy
    Ther Drug Monit 32:520-4. 2010
    ..Mean drug recovery was 99.8% for linezolid and 90.0% for the internal standard (para-toluic acid). The method was found to be precise and accurate and suitable for therapeutic drug monitoring of linezolid in routine clinical practice...
  11. doi request reprint Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients
    Dario Cattaneo
    Unit of Clinical Pharmacology, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Dept of Clinical Sciences L Sacco, University Hospital Luigi Sacco, Universita di Milano, Milan, Italy
    Pharmacol Res 65:198-203. 2012
    ....
  12. pmc Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events
    Cristina Gervasoni
    Department of Infectious Disease, L Sacco University Hospital, Milan, Italy
    PLoS ONE 8:e80242. 2013
    ....
  13. doi request reprint Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients
    Cristina Gervasoni
    Department of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy
    Antivir Ther 20:449-51. 2015
    ..Given the potential impact of ATV exposure on clinical outcome, in this retrospective study we sought to assess demographic and clinical factors influencing ATV plasma concentrations in a large cohort of HIV-infected patients...
  14. doi request reprint Comparison of the QMS Analyzer With HPLC-UV for the Quantification of Lamotrigine Concentrations in Human Plasma Samples
    Sara Baldelli
    Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Milan Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of Biomedical and Clinical Sciences, Luigi Sacco University Hospital, Universita degli Studi di Milano, Milan and Eugenio Medea Scientific Institute, Bosisio Parini, Italy
    Ther Drug Monit 37:689-94. 2015
    ..This study was designed to evaluate the performance of this immunoassay using a validated high-performance liquid chromatography-ultraviolet (HPLC-UV) method as the reference...
  15. doi request reprint Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study
    Vania Giacomet
    Pediatric Infectious Diseases Unit, L Sacco Hospital, University of Milan, Via G B Grassi 74, 20157, Milan, Italy
    Clin Drug Investig 35:419-26. 2015
    ..The aim of this study was to evaluate the long-term TDF renal safety profile, during a ten-year follow up...
  16. pmc Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?
    Cristina Gervasoni
    Department of Infectious Disease, L Sacco University Hospital, Milan, Italy
    PLoS ONE 10:e0123670. 2015
    ..Unboosted ATV may be selected for some patients because it has fewer gastrointestinal adverse effects, less hyperbilirubinemia and less impact on lipid profiles...
  17. pmc Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
    Maria Vittoria Cossu
    Unit of Clinical Pharmacology, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, Universita di Milano, Milan, Italy
    Drug Des Devel Ther 8:411-9. 2014
    ....
  18. doi request reprint Pharmacovigilance knowledge in family paediatricians. A survey study in Italy
    Paolo Pellegrino
    Unit of Clinical Pharmacology, CNR Institute of Neuroscience, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, Universita di Milano, 20157 Milan, Italy
    Health Policy 113:216-20. 2013
    ..Yet, FPs reported a poor compliance to the reporting of ADRs. A very high variability in ADRs reporting however, was observed among the regions, possibly because of variability of regional educational programmes dedicated to PV. ..
  19. doi request reprint Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma
    Sara Baldelli
    Unit of Clinical Pharmacology, L Sacco University Hospital, Milano, Italy
    Bioanalysis 8:275-83. 2016
    ..Novel oral anticoagulants are characterized by a wide therapeutic window, yet the determination of their plasma-drug concentrations may be useful in some clinical conditions...
  20. doi request reprint Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders
    Laura Milazzo
    Department of Biomedical and Clinical Sciences L Sacco, III Division of Infectious Diseases, University of Milan, Via GB Grassi 74, 20157 Milan, Italy Electronic address
    Int J Antimicrob Agents 45:545-9. 2015
    ....
  21. doi request reprint Lights and shadows of the actual European guidelines on bioanalytical method validation: the case of raltegravir
    Sara Baldelli
    Unit of Clinical Pharmacology, Institute of Neuroscience, Consiglio Nazionale delle Ricerche Department of Biomedical and Clinical Sciences, L Sacco University Hospital, Universita degli Studi di Milano, Milan and Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy
    Ther Drug Monit 36:739-45. 2014
    ....
  22. doi request reprint Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes
    Vania Giacomet
    From the Department of Pediatrics, L Sacco Hospital, University of Milan Unit of Clinical Pharmacology, L Sacco University Hospital, Università degli Studi di Milano Consiglio Nazionale delle Ricerche Institute of Neuroscience, Milan, Italy and Eugenio Medea Scientific Institute, Bosisio Parini LC, Italy
    Pediatr Infect Dis J 32:e403-5. 2013
    ..We describe the first 2 cases of vertically HIV-infected patients affected by kidney tubular dysfunction associated with polymorphisms in the ABCC genes. ..
  23. pmc Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis
    Stefania Antoniazzi
    Unit of Clinical Pharmacology, Department of Clinical Sciences, University Hospital Luigi Sacco, Universita di Milano, 20157 Milan, Italy
    Ital J Pediatr 38:11. 2012
    ..These findings highlight the importance of assessing common, not serious inflammatory states when oxatomide is prescribed in paediatric patients...
  24. doi request reprint Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count
    Laura Milazzo
    III Division of Infectious Diseases, Luigi Sacco University Hospital, Milan, Italy
    J Med Virol 86:97-101. 2014
    ....
  25. doi request reprint Seizures in patients with chronic hepatitis C treated with NS3/4A protease inhibitors: does pharmacological interaction play a role?
    Laura Milazzo
    Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy
    Pharmacology 92:235-7. 2013
    ..In this report we present a new onset of seizures occurring in 2 patients during anti-HCV therapy in association with Peg-IFN, ribavirin and HCV protease inhibitors...
  26. pmc Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans
    Clara Sciorati
    San Raffaele Scientific Institute, Stem Cell Research Institute, Milan, Italy
    Br J Pharmacol 160:1550-60. 2010
    ....
  27. doi request reprint Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy
    Francesco Roberto Simonetti
    Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy
    J Clin Virol 74:75-7. 2016
    ..We describe here the case of a patient who experienced a relapse of KS and a rebound of HHV-8 viremia two months after switching from a PI to an integrase inhibitor-based cART. ..
  28. doi request reprint Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring
    Alberto M Cappellari
    Department of Neuroscience, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, University of Milan Unit of Clinical Pharmacology Department of Biomedical and Clinical Sciences, Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, L Sacco University Hospital, Universita degli Studi di Milano, Milan Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Lecco and Department of woman, child and newborn health, Obstetric and Gynaecologic Emergency Unit, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, University of Milan, Italy
    Ther Drug Monit 37:285-7. 2015
    ..Afterward, trough plasma levels of LVT remained always within the therapeutic range until delivery, and no major increase of the drug daily dose was required. ..
  29. pmc Serotonin reuptake inhibitors in pregnancy: can genes help us in predicting neonatal adverse outcome?
    Valentina Giudici
    Department of Paediatrics, Hospital Luigi Sacco, Via GB Grassi 74, 20157 Milan, Italy
    Biomed Res Int 2014:276918. 2014
    ..This review describes possible relationship between SSRIs pharmacogenetics and different neonatal outcomes and summarizes the current pharmacogenetic inquiries in relation to maternal-foetal environment. ..
  30. doi request reprint Perceptions and patterns of use of generic drugs among Italian family pediatricians: first round results of a web survey
    Valentina Fabiano
    Department of Pediatrics, Universita degli Studi di Milano, Luigi Sacco Hospital, Via GB Grassi 74, Milan, Italy
    Health Policy 104:247-52. 2012
    ..More information about generic drugs and more research in the field of pediatric pharmacology are needed for increasing generic medicines prescription rate among Italian Family Pediatricians...
  31. ncbi request reprint Clinical pharmacokinetics of ibuprofen arginine
    Dario Cattaneo
    Department of Preclinical Sciences LITA Vialba, University of Milan, Via GB Grassi 74, Milan, Italy
    Curr Clin Pharmacol 5:239-45. 2010
    ..Taken together, the pharmacokinetic/dynamic characteristics of ibuprofen arginine can be considered particularly favorable for several clinical conditions, such as moderate/severe pain, in which a rapid pharmacologic effect is required...